Year |
Citation |
Score |
2016 |
Gregory MA, D'Alessandro A, Alvarez-Calderon F, Kim J, Nemkov T, Adane B, Rozhok AI, Kumar A, Kumar V, Pollyea DA, Wempe MF, Jordan CT, Serkova NJ, Tan AC, Hansen KC, et al. ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 113: E6669-E6678. PMID 27791036 DOI: 10.1073/Pnas.1603876113 |
0.684 |
|
2015 |
Alvarez-Calderon F, DeGregori J. Oncogenic drivers and mitochondrial dependency. Aging. 7: 148-9. PMID 25868642 |
0.524 |
|
2015 |
Alvarez-Calderon F, Gregory MA, Pham-Danis C, DeRyckere D, Stevens BM, Zaberezhnyy V, Hill AA, Gemta L, Kumar A, Kumar V, Wempe MF, Pollyea DA, Jordan CT, Serkova NJ, Graham DK, et al. Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1360-72. PMID 25547679 DOI: 10.1158/1078-0432.Ccr-14-2146 |
0.686 |
|
2015 |
Gregory MA, D'Alessandro A, Alvarez-Calderon F, Kim J, Nemkov T, Tan AC, Hansen KC, DeGregori J. Abstract C78: ATM/G6PD-dependent metabolic pathways promote mitochondrial redox homeostasis and resistance to FLT3 inhibition in acute myeloid leukemia Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C78 |
0.703 |
|
2013 |
Christoph S, Schlegel J, Alvarez-Calderon F, Kim YM, Brandao LN, DeRyckere D, Graham DK. Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission. Journal of Hematology & Oncology. 6: 10. PMID 23343252 DOI: 10.1186/1756-8722-6-10 |
0.358 |
|
2013 |
Alvarez-Calderon F, Gregory MA, DeGregori J. Using functional genomics to overcome therapeutic resistance in hematological malignancies. Immunologic Research. 55: 100-15. PMID 22941562 DOI: 10.1007/S12026-012-8353-Z |
0.582 |
|
2012 |
Alvarez-Calderon F, Zaberezhnyy V, Gemta L, Gregory MA, DeGregori JV. Abstract 1127: Bcr-Abl inhibition in leukemia cells creates metabolic addictions Cancer Research. 72: 1127-1127. DOI: 10.1158/1538-7445.Am2012-1127 |
0.699 |
|
2011 |
Alvarez-Calderon F, Gregory MA, DeGregori J. Abstract 3796: Inhibition of mitochondrial respiration synergizes with tyrosine kinase inhibitors to eliminate Bcr-Abl+ leukemia Cancer Research. 71: 3796-3796. DOI: 10.1158/1538-7445.Am2011-3796 |
0.703 |
|
2010 |
Gregory MA, Phang TL, Neviani P, Alvarez-Calderon F, Eide CA, O'Hare T, Zaberezhnyy V, Williams RT, Druker BJ, Perrotti D, Degregori J. Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl. Cancer Cell. 18: 74-87. PMID 20609354 DOI: 10.1016/J.Ccr.2010.04.025 |
0.648 |
|
Show low-probability matches. |